Prof Research published a new market report on home use lancing devices Market. It presents the largest 9 manufacturers of home use lancing devices. The report is a professional and in-depth study on the current state of the global home use lancing devices market with a focus on the Chinese market. The report provides key statistics on the market of home use lancing devices.  It is a valuable source of guidance and direction for companies and individuals interested of home use lancing devices industry.

The global home use lancing devices market was valued to be 227.87 million USD in 2020. The home use lancing devices production value is anticipated to have grown with a CAGR of 6.27% in the coming years to reach 328.22 million USD in 2026.

Abbott is the largest manufacturer of home use lancing devices in the world, it has a market share of 37.72% in value. Abbott’s reportable segments are Established Pharmaceutical Products, Nutritional Products, Diagnostic Products and Medical Devices.

Roche is the second-largest manufacturer of home use lancing devices in the world, it has a market share of 15.55% in value. It is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.

LifeScan is the third-largest manufacturer of home use lancing devices in the world, it has a market share of 12.36% in value. It is a diagnostic systems manufacturer with products focusing on the diabetes market, specifically blood glucose monitoring systems.

PHC Holdings is the fourth largest manufacturer of home use lancing devices in the world, it has a market share of 10.29% in value. The PHC Group provides products and services for diabetes management, life sciences and diagnostics, as well as enhanced healthcare solutions that are used by patients, healthcare professionals and researchers in over 125 countries.